O
DXCM icon

OppenheimerFunds’s DexCom DXCM Stock Holding History

OppenheimerFunds’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$19.9M Buy
668,044
+135,208
+25% +$4.75M 0.02% 541
2018
Q4 		$16M Sell
532,836
-2,780,068
-84% -$88.2M 0.02% 563
2018
Q3 		$118M Sell
3,312,904
-1,125,944
-25% -$34.9M 0.14% 170
2018
Q2 		$105M Sell
4,438,848
-1,540,012
-26% -$32.7M 0.13% 183
2018
Q1 		$111M Sell
5,978,860
-3,280
-0.1% -$48.5K 0.14% 169
2017
Q4 		$85.8M Buy
5,982,140
+2,937,300
+96% +$38.2M 0.1% 211
2017
Q3 		$37.2M Buy
3,044,840
+2,844,680
+1,421% +$50.3M 0.05% 381
2017
Q2 		$3.66M Sell
200,160
-208,400
-51% -$3.85M ﹤0.01% 845
2017
Q1 		$8.65M Buy
+408,560
New +$7.97M 0.01% 785
2016
Q3 		– Sell
-1,673,184
Closed -$33.2M – 1735
2016
Q2 		$33.2M Sell
1,673,184
-1,568,200
-48% -$26.7M 0.04% 423
2016
Q1 		$55M Sell
3,241,384
-313,712
-9% -$5.24M 0.07% 286
2015
Q4 		$72.8M Buy
3,555,096
+50,564
+1% +$1.05M 0.09% 239
2015
Q3 		$75.2M Sell
3,504,532
-2,577,468
-42% -$57.5M 0.1% 244
2015
Q2 		$122M Sell
6,082,000
-729,564
-11% -$12.8M 0.14% 180
2015
Q1 		$106M Buy
6,811,564
+381,384
+6% +$5.76M 0.12% 207
2014
Q4 		$88.5M Sell
6,430,180
-419,408
-6% -$5.13M 0.1% 226
2014
Q3 		$68.5M Sell
6,849,588
-711,924
-9% -$7.28M 0.08% 261
2014
Q2 		$75M Sell
7,561,512
-1,058,436
-12% -$9.38M 0.08% 257
2014
Q1 		$89.1M Sell
8,619,948
-112,548
-1% -$1.16M 0.11% 222
2013
Q4 		$77.3M Sell
8,732,496
-8,365,784
-49% -$66.2M 0.09% 240
2013
Q3 		$121M Buy
17,098,280
+7,394,224
+76% +$46.9M 0.08% 286
2013
Q2 		$54.5M Buy
+9,704,056
New +$46.5M 0.08% 291

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OppenheimerFunds's DXCM Position: Q1 2019 in Review

OppenheimerFunds increased its DexCom (DXCM) stake by 25% in Q1 2019, buying an estimated $4.75M and bringing the position to 668,044 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #541.

OppenheimerFunds first reported a position in DXCM in Q2 2013 and has held it in 22 quarters since. The position peaked at $122M in Q2 2015. 457 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

  • OppenheimerFunds held 668,044 shares of DexCom worth $19.9M as of Q1 2019.
  • OppenheimerFunds bought 135,208 DexCom shares in Q1 2019, an estimated $4.75M.
  • DexCom made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #541 holding.
  • OppenheimerFunds first reported a position in DexCom in Q2 2013 and has held it in 22 quarters since.
  • OppenheimerFunds's DexCom position peaked at $122M in Q2 2015.
  • 457 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.